These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 38004379)

  • 1. Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer.
    Alfaro I; Vega M; Romero C; Garrido MP
    Pharmaceuticals (Basel); 2023 Oct; 16(11):. PubMed ID: 38004379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Coding RNAs as Mediators of Epigenetic Changes in Malignancies.
    Kumar S; Gonzalez EA; Rameshwar P; Etchegaray JP
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-coding RNAs as potential targets in metformin therapy for cancer.
    Zhang Y; Wu Y; Liu Z; Yang K; Lin H; Xiong K
    Cancer Cell Int; 2024 Oct; 24(1):333. PubMed ID: 39354464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of non-coding RNAs in chemotherapy resistance of ovarian cancer.
    Shao Y; Li H; Du R; Meng J; Yang G
    J Cancer; 2018; 9(11):1966-1972. PubMed ID: 29896281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances of non-coding RNAs in ovarian cancer prognosis and therapeutics.
    Chen M; Lei N; Tian W; Li Y; Chang L
    Ther Adv Med Oncol; 2022; 14():17588359221118010. PubMed ID: 35983027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Emerging Role of Non-coding RNAs in Drug Resistance of Ovarian Cancer.
    Lan H; Yuan J; Zeng D; Liu C; Guo X; Yong J; Zeng X; Xiao S
    Front Genet; 2021; 12():693259. PubMed ID: 34512721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs in cancer: platforms and strategies for investigating the genomic "dark matter".
    Grillone K; Riillo C; Scionti F; Rocca R; Tradigo G; Guzzi PH; Alcaro S; Di Martino MT; Tagliaferri P; Tassone P
    J Exp Clin Cancer Res; 2020 Jun; 39(1):117. PubMed ID: 32563270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNAs and MiRNAs: New Targets for Resveratrol in Ovarian Cancer Research.
    Chaichian S; Bidgoli SA; Nikfar B; Moazzami B
    Curr Med Chem; 2023; 30(28):3238-3248. PubMed ID: 36372916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code.
    Cammarata G; Barraco N; Giusti I; Gristina V; Dolo V; Taverna S
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico screening of circulating tumor DNA, circulating microRNAs, and long non-coding RNAs as diagnostic molecular biomarkers in ovarian cancer: A comprehensive meta-analysis.
    Zhang L; Hu C; Huang Z; Li Z; Zhang Q; He Y
    PLoS One; 2021; 16(4):e0250717. PubMed ID: 33901236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
    Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
    World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Non-Coding RNAs in Colorectal Cancer: Focus on Long Non-Coding RNAs.
    Lulli M; Napoli C; Landini I; Mini E; Lapucci A
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer.
    Wu Y; Yang X; Xie Z; Hu H; Lei X; Niu D; Li S; Tuo L
    Comb Chem High Throughput Screen; 2022; 25(13):2127-2140. PubMed ID: 35366768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA and long non-coding RNA: molecular function and clinical value in breast and ovarian cancers.
    Panoutsopoulou K; Avgeris M; Scorilas A
    Expert Rev Mol Diagn; 2018 Nov; 18(11):963-979. PubMed ID: 30338716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers.
    Hashemipour M; Boroumand H; Mollazadeh S; Tajiknia V; Nourollahzadeh Z; Rohani Borj M; Pourghadamyari H; Rahimian N; Hamblin MR; Mirzaei H
    Gynecol Oncol; 2021 Apr; 161(1):314-327. PubMed ID: 33581845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of non-coding RNAs in vascular calcification and opportunities as therapeutic targets.
    Ryu J; Ahn Y; Kook H; Kim YK
    Pharmacol Ther; 2021 Feb; 218():107675. PubMed ID: 32910935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lncRNAs as Novel Biomarkers and Therapeutic Targets in Ovarian Cancer.
    Fu LL; Li CJ; Xu Y; Li LY; Zhou X; Li DD; Chen SX; Wang FG; Zhang XY; Zheng LW
    Crit Rev Eukaryot Gene Expr; 2017; 27(2):183-195. PubMed ID: 28845767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Emerging Role of Major Regulatory RNAs in Cancer Control.
    Dai X; Kaushik AC; Zhang J
    Front Oncol; 2019; 9():920. PubMed ID: 31608229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Coding RNAs in Oral Cancer: Emerging Roles and Clinical Applications.
    Dey S; Biswas B; Manoj Appadan A; Shah J; Pal JK; Basu S; Sur S
    Cancers (Basel); 2023 Jul; 15(15):. PubMed ID: 37568568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of miRNAs in ovarian cancer pathogenesis and therapeutic resistance - A focus on signaling pathways interplay.
    Ismail A; Abulsoud AI; Fathi D; Elshafei A; El-Mahdy HA; Elsakka EGE; Aglan A; Elkhawaga SY; Doghish AS
    Pathol Res Pract; 2022 Dec; 240():154222. PubMed ID: 36413828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.